Chemoinformaics analysis of 4-[2-Hydroxy-3-(4-hydroxyphenyl)propyl]phenol
Molecular Weight | 244.29 | nRot | 4 |
Heavy Atom Molecular Weight | 228.162 | nRig | 18 |
Exact Molecular Weight | 244.11 | nRing | 2 |
Solubility: LogS | -2.231 | nHRing | 0 |
Solubility: LogP | -0.644 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 2 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 3 | No. of Arom Bond | 12 |
nHA | 3 | APOL | 38.1247 |
nHD | 3 | BPOL | 16.0513 |
QED | 0.437 |
Synth | 3.963 |
Natural Product Likeliness | 1.541 |
NR-PPAR-gamma | 0.013 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.002 |
Pgp-sub | 0.337 |
HIA | 0.729 |
CACO-2 | -5.728 |
MDCK | 0.000144052 |
BBB | 0.471 |
PPB | 0.191313 |
VDSS | 0.435 |
FU | 0.716831 |
CYP1A2-inh | 0.014 |
CYP1A2-sub | 0.055 |
CYP2c19-inh | 0.024 |
CYP2c19-sub | 0.405 |
CYP2c9-inh | 0.003 |
CYP2c9-sub | 0.559 |
CYP2d6-inh | 0.003 |
CYP2d6-sub | 0.188 |
CYP3a4-inh | 0.006 |
CYP3a4-sub | 0.033 |
CL | 1.467 |
T12 | 0.631 |
hERG | 0.009 |
Ames | 0.618 |
ROA | 0.125 |
SkinSen | 0.402 |
Carcinogencity | 0.737 |
EI | 0.009 |
Respiratory | 0.04 |
NR-Aromatase | 0.015 |
Antiviral | No |
Prediction | 0.598482 |